HARBIN, PRC and NEW YORK, NY--(Marketwire - August 12, 2008) - American Tony Pharmaceutical, Inc., ("American Tony"), a manufacturer and distributor of pharmaceuticals and health care products in China, today announced that it has completed a reverse merger with Aim Smart Corporation ("Aim Smart") (OTCBB: AIMR).

Under the terms of the merger agreement, the former American Tony shareholders exchanged their shares for Aim Smart shares so that, upon the closing of the merger, the former American Tony shareholders own 96.7% of the outstanding shares of Aim Smart. Aim Smart intends to change its name to American Tony Pharmaceutical, Inc. and apply for a new trading symbol in the near future.

Mr. Mingli Yao, founder and CEO of American Tony, commented: "American Tony is a rapidly growing pharmaceutical company. We offer unique traditional Chinese medicines combined with elements of Western medicine, and market our products throughout China. We are pleased to be taking the next step in American Tony's history, by becoming a publicly traded company. We look forward to rewarding our shareholders with opportunities associated with our vision of becoming one of the largest pharmaceutical companies in China through acquisitions and organic growth."

About American Tony Pharmaceutical, Inc.

American Tony Pharmaceutical, Inc. develops, manufactures and markets pharmaceutical and health care products through its wholly-owned subsidiary, Harbin Tianmu Pharmaceutical Co., Ltd. ("Tianmu Pharmaceutical"). Tianmu Pharmaceutical was founded in 1999 in Harbin, China. All of Tianmu Pharmaceutical's business takes place in the People's Republic of China. For further information visit our website at www.tmyy.com.cn.

Aim Smart reported the American Tony merger on a Form 8-K Report filed with the Securities and Exchange Commission (SEC) on July 30, 2008. The report provides substantial additional details regarding the merger between Aim Smart and American Tony and is available at www.sec.gov.

Forward-Looking Statements: This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's periodic reports filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that the Company's expectations will be achieved. The Company does not assume any duty to publicly update or revise the material contained herein.

Contact Information: FOR MORE INFORMATION, CONTACT: Investor Relations: Grayling Global Ms. Leslie Wolf-Creutzfeldt 646-284-9472 lwolf-creutzfeldt@hfgcg.com